Drug Channels

This is my final post of 2006. I'm grateful for the positive response to my blog and very much appreciate the many positive emails and c...

Here are a few noteworthy news items on AMP and PDMA that I want to recommend: 1. Roundtable: Deficit Reduction Act (Pharmaceutical Executi...

Can’t get enough PDMA news? Well, head over to Jayne Juvan’s surprisingly readable legal analysis of the recent injunction entitled RX USA W...

What will the injunction against the Prescription Drug Marketing Act (PDMA) mean in the pharmaceutical industry? (For background, see No PDM...

The pedigree requirements of the Prescription Drug Marketing Act (PDMA) are back on hold. This is a big loss for the FDA and a big win for s...

Last Thursday's New York Times included some very sloppy reporting about Wal Mart Stores Inc (WMT). See Side Effects at the Pharmacy . ...

Looks like the PDMA will not be going into effect after all. I've been skeptical about the injunction filed by a group of secondary whol...

Have you ever wondered where spammers get their counterfeit Viagra? Or why U.S. Senators don’t care? If so, then you should check out The Ph...

Today’s Wall Street Journal has a very good overview of key issues for the generic industry, such as biogenerics and the FDA’s generic appro...

Does anyone still believe that Wal-Mart will not shake up the pharmacy industry? Wal Mart Stores Inc (WMT) just expanded its $4 generic prog...

I don't normally agree with the New York Times editorial page, but it looks like they agree with me. On Monday morning, I posted CMS as ...

I’m blogging to you live from my hotel at the NACDS/HDMA RFID conference so I can opine real-time on the FDA’s hot-off-the-press pedigree d...